Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial
重组人尿激酶原治疗急性缺血性卒中发作后4.5小时内的疗效和安全性:一项3期随机临床试验
期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.25415
Song, Haiqing; Wang, Yuan; Ma, Qingfeng; Feng, Wuwei; Liu, Rui; Lv, Xiaomei; Huang, Lijuan; Li, Yifan; Yang, Yi; Geng, Deqin; Zhu, Jianguo; Wei, Yan; Chen, Huisheng; Zhu, Runxiu; Zhai, Qijin; Guo, Jing; Liu, Bo; Zhao, Shigang; Wang, Yuping